Canadian well being tech firm PointClickCare has acquired Affected person Sample, a value-based care digital well being document and built-in care administration platform.
Affected person Sample works with Medicare Benefit Particular Wants Plans, PACE applications and ACO REACH individuals.
The New York-based firm gives Care Coach, a workflow administration program to assist organizations handle fee-for-service and value-based care sufferers, and PDPM Coach, which assists with value-based care reimbursements.
PointClickCare focuses on elder care, together with the long-term and post-acute care market, and the firm says the mixed choices will assist suppliers undertake risk-bearing preparations with no need to make use of a number of platforms.
“As our prospects proceed to embrace value-based care and see the success of this mannequin, we’re excited to deploy Affected person Sample’s care administration platform. Care fashions will proceed to evolve, and this strategic funding is one other instance of our dedication to serving to our prospects thrive on this evolving market, particularly, the chance to succeed with this shift to danger,” Travis Palmquist, senior vp and basic supervisor of senior care at PointClickCare, mentioned in a press release.
THE LARGER TREND
PointClickCare has acquired a number of corporations to broaden its senior-focused portfolio, together with QuickMar in 2019, a publish acute care administration system. A 12 months later, it introduced its acquisition of Collective Medical, a cross-continuum coordinated care platform.
In October, PointClickCare launched Virtual Health, a telemedicine service for expert nursing services that provides 24/7 entry to hospitalists. It additionally introduced a partnership with Icon, a communication and engagement platform for senior communities.
A month later, the well being tech firm mentioned it signed a take care of pharma large Pfizer to share its real-world information on seniors, particularly these in long-term care services, which might assist affect Pfizer’s choices on new therapies.
In the meantime, in March of final 12 months, Affected person Sample garnered $2 million in seed funding, bringing its whole increase to $3.1 million, according to Crunchbase.
Aimee Cardwell will supply extra element at her HIMSS23 session “The Defender’s Benefit: Profitable by Utilizing the Excessive Floor.” It’s scheduled for Tuesday, April 18, at 3-4 p.m. CT on the South Constructing, Stage 4, in room S406 B.